Although nintedanib attenuated many genes associated with IPF that were upregulated by TGFβ1, nintedanib also significantly increased the expression of seven genes with a ≥0.5 log2FC. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.